[ad_1]
Morphic’s stock rocketed Monday, after the biopharmaceutical company announced an agreement to be acquired by Eli Lilly in a cash deal valued at about $3.2 billion.
[ad_2]
Source link
[ad_1]
Morphic’s stock rocketed Monday, after the biopharmaceutical company announced an agreement to be acquired by Eli Lilly in a cash deal valued at about $3.2 billion.
[ad_2]
Source link